Come hear David Anderson, PhD speak at SCOPE on Tuesday February 13th at 5:30pm.  David will be presenting Clinical ink’s latest offering, GlucoseReady™, a fully integrated GCP compliant digital platform designed for the new era of cardiometabolic clinical trials. The suite of tools includes therapeutic area-specific electronic clinical outcome assessments (eCOA), blood (BGM) and continuous glucose monitoring (CGM). Also available are integrations with digital weight scales and actigraphy devices.